ReviewArchives of microbiology2025
Redefining acne treatment: emerging role of probiotics in dermatology.
Review in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Bacterial Landscape of Facial Skin: From Homeostasis to Skin Conditions.Dermatology and therapy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Acne is a common dermatological condition that requires novel therapeutic strategies. Probiotics, live microorganisms that confer health benefits, have emerged as a promising option for acne management. This review summarizes current evidence on the role of probiotics, focusing on their ability to modulate the skin microbiota, reduce inflammation, and influence the skin-gut axis. Both oral and topical probiotic applications have shown potential-oral formulations primarily act through gut-skin immune modulation, whereas topical preparations directly target the cutaneous microbiota and local inflammation. Certain strains demonstrate antimicrobial activity against acne-associated bacteria, offering a targeted approach. Their use alongside conventional therapies and the development of topical formulations further expand treatment possibilities. As a personalized and well-tolerated intervention, probiotics have the potential to improve acne outcomes and enhance patients' quality of life. However, clinical evidence is limited by the scarcity of large randomized controlled trials, and further studies are needed to confirm efficacy and optimize treatment protocols. Future research should prioritize strain-specific recommendations, dosage optimization, and integration with precision dermatology.
Indexed as
Identifiers
41264021What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.